2 months ago
CORT
AnalystsDavid AmsellemDavid Amsellem's Stock Forecasts
AnalystsDavid Amsellem
Analyst Ranking
Top 11%
#507 out of 4908 analysts
Average Return
+9.61%
Win Rate
56%63 out of 112
Risk vs Reward
Poor
Good
David Amsellem's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Amneal Pharmaceuticals IncAMRX | +222.28% | $2.02 | $6.51 | 2023-05-08 - 2024-05-07 | Strong Buy |
Horizon Therapeutics Public Ltd CoHZNP | +189.77% | $31.56 | $91.45 | 2020-04-14 - 2021-04-14 | Strong Buy |
Corcept Therapeutics IncCORT | +117.02% | $32.67 | $70.90 | 2024-07-01 - 2025-06-16 | Strong Buy |
Xeris Biopharma Holdings IncXERS | +105.93% | $1.69 | $3.47 | 2023-11-10 - 2024-11-08 | Strong Buy |
Corcept Therapeutics IncCORT | +96.29% | $36.12 | $70.90 | 2024-07-30 - 2025-06-16 | Strong Buy |
David Amsellem Analyst Color
Get additional color on David Amsellem's coverage of popular stocks
4 months ago
CORT
5 months ago
TEVA
7 months ago
AMRX
8 months ago
INDV
9 months ago
CORT
10 months ago
NBIX
a year ago
CORT
a year ago
AMRX
a year ago
JAZZ
a year ago
IRWD
a year ago
TEVA
2 years ago
AVDL
2 years ago
AXSM
2 years ago
AMRX
2 years ago
CORT
2 years ago
IRWD
2 years ago
SUPN
2 years ago
RVNC
2 years ago
SUPN
2 years ago
HRMY
3 years ago
HZNP
3 years ago
SUPN
3 years ago
AMPH
3 years ago
COLL
David Amsellem's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Biogen IncBIIB | 1 | Hold | $115.00 | -12.24% | Reiterates | 5 days ago |
Amgen IncAMGN | 3 | Strong Buy | $328.00 | +10.98% | Maintains | a month ago |
Organon & CoOGN | 6 | Strong Buy | $18.00 | +76.64% | Maintains | a month ago |
Collegium Pharmaceutical IncCOLL | 7 | Hold | $37.00 | +24.54% | Reiterates | a month ago |
Jazz Pharmaceuticals PLCJAZZ | 9 | Strong Buy | $147.00 | +34.08% | Reiterates | a month ago |
Neurocrine Biosciences IncNBIX | 7 | Strong Buy | $154.00 | +23.20% | Reiterates | a month ago |
Bristol Myers Squibb CoBMY | 1 | Strong Buy | $65.00 | +33.58% | Initiates Coverage On | 2 months ago |
Corcept Therapeutics IncCORT | 7 | Strong Buy | $131.00 | +84.77% | Maintains | 2 months ago |
Amphastar Pharmaceuticals IncAMPH | 7 | Hold | $32.00 | +23.17% | Maintains | 3 months ago |
Optinose IncOPTN | 3 | Hold | $9.00 | -6.25% | Downgrades | 3 months ago |
Xeris Biopharma Holdings IncXERS | 5 | Hold | $4.00 | -9.09% | Reiterates | 3 months ago |
Indivior PLCINDV | 5 | Strong Buy | $13.00 | -8.32% | Maintains | 3 months ago |
Viatris IncVTRS | 7 | Hold | $10.00 | +11.23% | Reiterates | 3 months ago |
Teva Pharmaceutical Industries LtdTEVA | 7 | Strong Buy | $30.00 | +71.43% | Maintains | 5 months ago |
Intra Cellular Therapies IncITCI | 1 | Hold | $132.00 | +0.10% | Downgrades | 5 months ago |
Avadel Pharmaceuticals PLCAVDL | 4 | Strong Buy | $13.00 | +36.84% | Maintains | 5 months ago |
Sage Therapeutics IncSAGE | 1 | Strong Buy | $9.00 | -0.77% | Maintains | 5 months ago |
Amneal Pharmaceuticals IncAMRX | 4 | Strong Buy | $11.00 | +35.64% | Maintains | 7 months ago |
Alkermes PLCALKS | 7 | Strong Buy | $37.00 | +25.76% | Reiterates | 8 months ago |
Ani Pharmaceuticals IncANIP | 1 | Strong Buy | $68.00 | +5.77% | Initiates Coverage On | 8 months ago |
Supernus Pharmaceuticals IncSUPN | 10 | Hold | $36.00 | +10.87% | Downgrades | 9 months ago |
Revance Therapeutics IncRVNC | 7 | Strong Buy | $6.00 | +64.38% | Maintains | 10 months ago |
Bausch Health Companies IncBHC | 4 | Strong Sell | $3.00 | -49.24% | Downgrades | a year ago |
Pacira Biosciences IncPCRX | 7 | Strong Buy | $42.00 | +72.56% | Maintains | a year ago |
Aquestive Therapeutics IncAQST | 1 | Strong Buy | $10.00 | N/A | Initiates Coverage On | a year ago |
Ironwood Pharmaceuticals IncIRWD | 3 | Strong Buy | $21.00 | N/A | Maintains | a year ago |
Axsome Therapeutics IncAXSM | 3 | Strong Buy | $113.00 | N/A | Maintains | a year ago |
Cerevel Therapeutics Holdings IncCERE | 2 | Hold | $45.00 | N/A | Downgrades | 2 years ago |
Tvardi Therapeutics IncTVRD | 3 | Hold | $12.00 | N/A | Downgrades | 2 years ago |
Harmony Biosciences Holdings IncHRMY | 3 | Strong Buy | $42.00 | N/A | Maintains | 2 years ago |
Eagle Pharmaceuticals IncEGRX | 2 | Strong Sell | $17.00 | N/A | Downgrades | 2 years ago |
Karuna Therapeutics IncKRTX | 1 | Strong Buy | $285.00 | N/A | Initiates Coverage On | 2 years ago |
Horizon Therapeutics Public Ltd CoHZNP | 3 | Strong Buy | $110.00 | N/A | Maintains | 3 years ago |
Antares Pharma IncATRS | 1 | Hold | $5.60 | N/A | Downgrades | 3 years ago |
Endo International PLCENDPQ | 3 | Hold | $3.00 | N/A | Maintains | 3 years ago |
Biodelivery Sciences International IncBDSI | 1 | Hold | $5.60 | N/A | Downgrades | 3 years ago |
Adamas Pharmaceuticals IncADMS | 1 | Hold | $8.00 | N/A | Downgrades | 4 years ago |
Evofem Biosciences IncEVFM | 1 | Strong Buy | $165.00 | N/A | Initiates Coverage On | 5 years ago |
Impax Laboratories IncIPXL | 1 | Hold | N/A | N/A | Upgrades | 8 years ago |
Societal Cdmo IncSCTL | 1 | Strong Buy | $12.00 | N/A | Initiates Coverage On | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.